Legal & General Group’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.22M | Buy |
437,681
+74,372
| +20% | +$207K | ﹤0.01% | 2174 |
|
2025
Q1 | $1.3M | Buy |
363,309
+18,223
| +5% | +$65.4K | ﹤0.01% | 2081 |
|
2024
Q4 | $1.09M | Buy |
345,086
+68,256
| +25% | +$215K | ﹤0.01% | 2214 |
|
2024
Q3 | $781K | Buy |
+276,830
| New | +$781K | ﹤0.01% | 2317 |
|
2024
Q2 | – | Sell |
-254,652
| Closed | -$202K | – | 3435 |
|
2024
Q1 | $202K | Sell |
254,652
-15,768
| -6% | -$12.5K | ﹤0.01% | 2676 |
|
2023
Q4 | $257K | Hold |
270,420
| – | – | ﹤0.01% | 2660 |
|
2023
Q3 | $292K | Buy |
270,420
+89,373
| +49% | +$96.5K | ﹤0.01% | 2634 |
|
2023
Q2 | $162K | Buy |
181,047
+14,276
| +9% | +$12.8K | ﹤0.01% | 2781 |
|
2023
Q1 | $141K | Buy |
166,771
+13,717
| +9% | +$11.6K | ﹤0.01% | 2703 |
|
2022
Q4 | $142K | Hold |
153,054
| – | – | ﹤0.01% | 2721 |
|
2022
Q3 | $260K | Buy |
153,054
+8,526
| +6% | +$14.5K | ﹤0.01% | 2526 |
|
2022
Q2 | $310K | Buy |
144,528
+45,186
| +45% | +$96.9K | ﹤0.01% | 2477 |
|
2022
Q1 | $353K | Buy |
99,342
+2,273
| +2% | +$8.08K | ﹤0.01% | 2488 |
|
2021
Q4 | $362K | Buy |
97,069
+44,054
| +83% | +$164K | ﹤0.01% | 2515 |
|
2021
Q3 | $392K | Buy |
53,015
+22,980
| +77% | +$170K | ﹤0.01% | 2488 |
|
2021
Q2 | $400K | Buy |
+30,035
| New | +$400K | ﹤0.01% | 2378 |
|